Bibliography
Kupelian, P., Kuban, D., Thames, H., Levy, L., Horwitz, E., Martinez, A., Michalski, J., Pisansky, T., Sandler, H., Shipley, W., Zelefsky, M., & Zietman, A. (2005). Improved biochemical relapse-free survival with increased external radiation doses in patients with localized prostate cancer: The combined experience of nine institutions in patients treated in 1994 and 1995. International Journal of Radiation Oncology*Biology*Physics, 61(2), 415â419.
Authors
12
- Patrick Kupelian (first)
- Deborah Kuban (additional)
- Howard Thames (additional)
- Larry Levy (additional)
- Eric Horwitz (additional)
- Alvaro Martinez (additional)
- Jeff Michalski (additional)
- Thomas Pisansky (additional)
- Howard Sandler (additional)
- William Shipley (additional)
- Michael Zelefsky (additional)
- Anthony Zietman (additional)
References
20
Referenced
91
10.1016/S0360-3016(02)02885-7
/ Int J Radiat Oncol Biol Phys / Lack of radiation dose response for patients with low-risk clinically localized prostate cancer by Hurwitz (2002)10.1016/S0360-3016(02)02829-8
/ Int J Radiat Oncol Biol Phys / Prostate cancer radiation dose response by Pollack (2002)10.1016/S0360-3016(00)00620-9
/ Int J Radiat Oncol Biol Phys / External beam radiotherapy dose response characteristics of 1127 men with prostate cancer treated in the PSA era by Pollack (2000)10.1016/S0360-3016(02)02857-2
/ Int J Radiat Oncol Biol Phys / High-dose intensity modulated radiation therapy for prostate cancer by Zelefsky (2002)10.1016/S0090-4295(99)00380-5
/ Urology / Importance of high radiation doses (72 Gy or greater) in the treatment of stage T1-T3 adenocarcinoma of the prostate by Lyons (2000)10.1016/S0360-3016(99)00455-1
/ Int J Radiat Oncol Biol Phys / Higher than standard radiation doses (72 Gy or greater) with or without androgen deprivation in the treatment of localized prostate cancer by Kupelian (2000)10.1016/S0360-3016(03)00569-8
/ Int J Radiat Oncol Biol Phys / Dose escalation for localized prostate cancer by Symon (2003)10.1016/S0360-3016(02)02978-4
/ Int J Radiat Oncol Biol Phys / Dose escalation in localized prostate cancer by Zietman (2002)10.1016/S0360-3016(99)00235-7
/ Int J Radiat Oncol Biol Phys / The importance of adequate follow-up in defining treatment success after external beam irradiation for prostate cancer by Vicini (1999)10.1016/S0360-3016(03)00722-3
/ Int J Radiat Oncol Biol Phys / Influence of follow-up bias on PSA failure after external beam radiotherapy for localized prostate cancer by Coen (2003)10.1016/S0360-3016(03)00632-1
/ Int J Radiat Oncol Biol Phys / Long-term multi-institutional analysis of stage T1-T2 prostate cancer treated with radiotherapy in the PSA era by Kuban (2003)-
Consensus statement: Guidelines for PSA following radiation therapy. American Society for Therapeutic Radiology and Oncology Consensus Panel. Int J Radiat Oncol Biol Phys 1997;37:1035–1041
(
10.1016/S0360-3016(97)00002-3
) 10.1016/S0360-3016(03)00631-X
/ Int J Radiat Oncol Biol Phys / Comparison of alternative biochemical failure definitions based on clinical outcome in 4839 prostate cancer patients treated by external beam radiotherapy between 1986 and 1995 by Thames (2003)10.1016/S0090-4295(02)01814-9
/ Urology / Evolution of the presentation and pathologic and biochemical outcomes after radical prostatectomy for patients with clinically localized prostate cancer diagnosed during the PSA era by Ung (2002)10.1200/JCO.1999.17.10.3167
/ J Clin Oncol / Declining rates of extracapsular extension after radical prostatectomy by Jhaveri (1999)10.1016/S0360-3016(03)00630-8
/ Int J Radiat Oncol Biol Phys / Improvement in relapse-free survival throughout the PSA era in patients with localized prostate cancer treated with definitive radiotherapy by Kupelian (2003)10.1056/NEJMoa022749
/ N Engl J Med / Noninvasive detection of clinically occult lymph-node metastases in prostate cancer by Harisinghani (2003)10.1016/S0360-3016(98)00502-1
/ Int J Radiat Oncol Biol Phys / Static field intensity modulation to treat a dominant intra-prostatic lesion to 90 Gy compared to seven field 3-dimensional radiotherapy by Pickett (1999)10.1016/S0360-3016(03)00766-1
/ Int J Radiat Oncol Biol Phys / Technical aspects of daily online positioning of the prostate for three-dimensional conformal radiotherapy using an electronic portal imaging device by Herman (2003)10.1016/S0360-3016(03)00086-5
/ Int J Radiat Oncol Biol Phys / Prediction of the benefits from dose-escalated hypofractionated intensity-modulated radiotherapy for prostate cancer by Am (2003)
Dates
Type | When |
---|---|
Created | 20 years, 7 months ago (Jan. 25, 2005, 11:16 p.m.) |
Deposited | 5 years, 4 months ago (April 5, 2020, 8:27 a.m.) |
Indexed | 1 year, 1 month ago (July 22, 2024, 1:53 a.m.) |
Issued | 20 years, 6 months ago (Feb. 1, 2005) |
Published | 20 years, 6 months ago (Feb. 1, 2005) |
Published Print | 20 years, 6 months ago (Feb. 1, 2005) |
@article{Kupelian_2005, title={Improved biochemical relapse-free survival with increased external radiation doses in patients with localized prostate cancer: The combined experience of nine institutions in patients treated in 1994 and 1995}, volume={61}, ISSN={0360-3016}, url={http://dx.doi.org/10.1016/j.ijrobp.2004.05.018}, DOI={10.1016/j.ijrobp.2004.05.018}, number={2}, journal={International Journal of Radiation Oncology*Biology*Physics}, publisher={Elsevier BV}, author={Kupelian, Patrick and Kuban, Deborah and Thames, Howard and Levy, Larry and Horwitz, Eric and Martinez, Alvaro and Michalski, Jeff and Pisansky, Thomas and Sandler, Howard and Shipley, William and Zelefsky, Michael and Zietman, Anthony}, year={2005}, month=feb, pages={415–419} }